Human Hindbrain Organoid Functional Assay Services.

Food and Drug Administration See every open bid from this agency →

In plain English

The FDA wants human iPSC-derived hindbrain organoids and functional testing using 3D multi-electrode array technology. The work includes 12 deliveries to the FDA White Oak Campus in Silver Spring, Maryland: 96 organoids initially, followed by 48 per delivery, plus drug testing, data analysis, and reports. The expected performance period is 18 months, and responsible sources may submit quotations even though the FDA identified OrganoTherapeutics SARL as the only known source.

About this opportunity

The U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Division of Applied Regulatory Science (DARS), intends to award a sole-source, Firm-Fixed-Price purchase order to OrganoTherapeutics SARL for Human iPSC-Derived Hindbrain Organoid Functional Assay Services. The requirement includes the provision of human induced pluripotent stem cell (iPSC)-derived hindbrain organoids and associated materials necessary to support in vitro research evaluating drug-induced effects on respiratory-relevant neural circuits. The contractor will also perform functional characterization of the organoids using three-dimensional multi-electrode array (3D MEA) technology to…

Time remaining

Closes Sep 17, 2026

03Days

12Hours

27Min

47Sec